Farabi Pharmaceutical (XTEH:DFRB1) Quick Ratio: 0.00 (As of . 20)


What is Farabi Pharmaceutical Quick Ratio?

Farabi Pharmaceutical XTEH:DFRB1 Quick Ratio is 0.00 as of . 20.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Farabi Pharmaceutical's quick ratio for the quarter that ended in . 20 was 0.00.

Farabi Pharmaceutical has a quick ratio of 0.00. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Farabi Pharmaceutical's Quick Ratio or its related term are showing as below:

XTEH:DFRB1's Quick Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.45
* Ranked among companies with meaningful Quick Ratio only.

Farabi Pharmaceutical  (XTEH:DFRB1) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.

Farabi Pharmaceutical Quick Ratio Related Terms

Farabi Pharmaceutical Quick Ratio Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical Quick Ratio Chart

Farabi Pharmaceutical Annual Data
Trend
Quick Ratio

Farabi Pharmaceutical Quarterly Data
Quick Ratio

XTEH:DFRB1 vs IMNPQ, INNV: Quick Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Farabi Pharmaceutical's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Farabi Pharmaceutical Quick Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Farabi Pharmaceutical's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Farabi Pharmaceutical's Quick Ratio falls into.


Farabi Pharmaceutical Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Farabi Pharmaceutical's Quick Ratio for the fiscal year that ended in . 20 is calculated as

Quick Ratio (A: . 20 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(-)/
=

Farabi Pharmaceutical's Quick Ratio for the quarter that ended in . 20 is calculated as

Quick Ratio (Q: . 20 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(-)/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 0.00 mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a Quick Ratio of 0.00 as of . 20. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's Quick Ratio too high?
Farabi Pharmaceutical's current Quick Ratio is 0.00.
How does Farabi Pharmaceutical's Quick Ratio compare to IMNPQ and INNV?
Farabi Pharmaceutical's Quick Ratio of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median Quick Ratio is 1.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 996 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Farabi Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farabi Pharmaceutical's current Quick Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current Quick Ratio of 0.00. The current Quick Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current Quick Ratio is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.